In several dierent cell lines, Bcl-2 prevents the induction of apoptosis (DNA fragmentation, PARP cleavage, phosphatidylserine exposure) by the pro-oxidant terbutylhydroperoxide (t-BHP) but has no cytoprotective eect when apoptosis is induced by the thiol crosslinking agent diazenedicarboxylic acid bis 5N,N-dimethylamide (diamide). Both t-BHP and diamide cause a disruption of the mitochondrial transmembrane potential DC m that is not inhibited by the broad spectrum caspase inhibitor Z-VAD.fmk, although Z-VAD.fmk does prevent nuclear DNA fragmentation and poly(ADP-ribose) polymerase cleavage in these models. Bcl-2 stabilizes the DC m of t-BHP-treated cells but has no inhibitory eect on the DC m collapse induced by diamide. As compared to normal controls, isolated mitochondria from Bcl-2 overexpressing cells are relatively resistant to the induction of DC m disruption by t-BHP in vitro. Such Bcl-2 overexpressing mitochondria also fail to release apoptosis-inducing factor (AIF) and cytochrome c from the intermembrane space, whereas control mitochondria not overexpressing Bcl-2 do liberate AIF and cytochrome c in response to t-BHP. In contrast, Bcl-2 does not confer protection against diamidetriggered DC m collapse and the release of AIF and cytochrome c. This indicates that Bcl-2 suppresses the permeability transition (PT) and the associated release of intermembrane proteins induced by t-BHP but not by diamide. To further investigate the mode of action of Bcl-2, semi-puri®ed PT pore complexes were reconstituted in liposomes in a cell-free, organelle-free system. Recombinant Bcl-2 or Bcl-X L proteins augment the resistance of reconstituted PT pore complexes to pore opening induced by t-BHP. In contrast, mutated Bcl-2 proteins which have lost their cytoprotective potential also lose their PTmodulatory capacity. Again, Bcl-2 fails to confer protection against diamide in this experimental system. The reconstituted PT pore complex itself cannot release cytochrome c encapsulated into liposomes. Altogether these data suggest that pro-oxidants, thiol-reactive agents, and Bcl-2 can regulate the PT pore complex in a direct fashion, independently from their eects on cytochrome c. Furthermore, our results suggest a strategy for inducing apoptosis in cells overexpressing apoptosis-inhibitory Bcl-2 analogs.
Introduction
Bcl-2 belongs to a family of proteins with cardinal cytoprotective, apoptosis-inhibitory properties (Kroemer, 1997; Reed, 1997) . Its de®ciency is deleterious for certain cell types including lymphocytes, melanocytes (Nakayama et al., 1994) , intestinal epithelial cells (Kamada et al., 1995) , and some classes of neurons (Michaelidis et al., 1996) . The clinical importance of Bcl-2 and of its anti-apoptotic homologs (Bcl-X L , Bclw, B¯-1, Brag-1, Mch-1 and A1) resides in their function as proto-oncogenes participating in oncogenesis and in the development of chemotherapy resistance (Kroemer, 1997; Reed, 1997) . The mechanisms by which Bcl-2 inhibits apoptosis are only partially elucidated. Most experimental data suggest that Bcl-2 has to act on mitochondrial membranes to prevent apoptosis. Indeed, Bcl-2 is found preferentially in the contact site between the inner and the outer mitochondrial membranes (Krajewski et al., 1993) and stabilizes mitochondrial membrane function on two levels. On the one hand, Bcl-2 prevents the apoptosis-associated release of caspase-and nucleaseactivating factors from the mitochondrial intermembrane space, via the outer mitochondrial membrane. It thus causes the mitochondrial retention of factors such as cytochrome c (Kluck et al., 1997; Yang et al., 1997) and a mitochondrial protease (apoptosis-inducing factor, AIF) (Susin et al., 1997a; Zamzami et al., 1996) , in conditions in which these factors would be released in control cells not overexpressing Bcl-2. In addition to this eect on the outer mitochondrial membrane, Bcl-2 prevents the opening of the mitochondrial megachannel (also called permeability transition pore complex, PTPC) which accounts for the permeability transition (PT) resulting in disruption of the inner mitochondrial transmembrane potential (DC m ) during apoptosis (Susin et al., 1997a; Zamzami et al., 1995 Zamzami et al., , 1996 . The PTPC is a composite structure in which proteins from the cytosol (hexokinase), the outer mitochondrial membrane (porin), the inner membrane (adenine nucleotide translocator), and the matrix (cyclophilin D) cooperate to form a channel with several levels of conductance (maximum molecular cut-o: *1500 Da) and little if any ion selectivity (Bernardi, 1996; Beutner et al., 1996; Ichas et al., 1997; Zoratti and SzaboÁ , 1995) . Inhibition of PTPC by ligands acting on the adenine nucleotide translocator can prevent apoptosis (Marchetti et al., 1996a; Polyak et al., 1997; Zamzami et al., 1996) , and Bcl-2 appears to act as an inhibitor of PTPC opening (Susin et al., 1997a; Zamzami et al., 1995 Zamzami et al., , 1996 .
Changes in redox equilibria and reactive oxygen species (ROS) have been known for long to be involved in apoptosis, and this at two levels. At the ®rst level, oxidative stress (depletion of glutathione, oxidation of thiols, and addition of ROS donors) can serve as a facultative inducer of PTPC opening and apoptosis. Although ROS are potent inducers of PTPC opening in isolated mitochondria (Bernardi, 1996; Zoratti and SzaboÁ , 1995) and of apoptosis in cells (Hockenbery et al., 1993; Kane et al., 1993) , ROS are not absolutely required for PTPC opening or apoptosis. These phenomena can be induced in the absence of oxygen, in conditions in which the generation of oxygen radicals is precluded (Jacobson and Ra, 1995; Scorrano et al., 1997; Shimizu et al., 1995) . At the second level, ROS are formed as byproducts of apoptosis (Hockenbery et al., 1993; Kane et al., 1993) , perhaps as a result of uncoupling of the respiratory chain due to PTPC opening , and/or as a consequence of cytochrome c release or inactivation (Adachi et al., 1997) . Bcl-2 has been shown previously to act on these two levels. On the one hand, it protects cells and mitochondria against pro-oxidants such as H 2 O 2 and ter-butylhydroperoxide (t-BHP) (Hockenbery et al., 1993) . On the other hand, Bcl-2 suppresses the generation of ROS associated with apotosis (Kane et al., 1993) , an eect which is probably explained by its capacity to stabilize mitochondrial membranes and to prevent the mitochondrial generation of ROS (Kluck et al., 1997; Susin et al., 1997a; Yang et al., 1997; Zamzami et al., 1995 Zamzami et al., , 1996 .
When investigating the spectrum of apoptosisinhibitory activities of Bcl-2, we have previously obtained preliminary data suggesting that Bcl-2 fails to protect cells against diazenedicarboxylic acid bis 5N,N-dimethylamide (diamide) . Diamide is a thiol-crosslinking agent which acts on non-glutathione thiols to induce apoptosis (Sato et al., 1995) and PTPC opening (Costantini et al., 1995; Petronilli et al., 1994) . The available data are compatible with the hypothesis that diamide acts on (a) mitochondrial inner membrane protein(s) to induce apoptosis (Costantini et al., 1995; Majima et al., 1993; Marchetti et al., 1997; Petronilli et al., 1994) . Intrigued by these observations, we decided to study the reason of why Bcl-2 fails to prevent diamide-induced apoptosis. When comparatively assessing the eect of Bcl-2 on diamide-and t-BHP-induced apoptosis, we found that diamide has the exquisite capacity to enforce PT even in the presence of Bcl-2. This evidence has been obtained in three very dierent experimental systems: (i) in intact cells; (ii) in a cell-free system involving puri®ed mitochondria; and (iii) in PTPC reconstituted into liposomes in a cell-free, organelle-free system. The data reported in this work thus suggest a novel strategy for overcoming Bcl-2 mediated apoptosis resistance. Moreover, they provide new insights into the mechanism by which Bcl-2 inhibits apoptosis. Figure 1 Eect of t-BHP and diamide on apoptosis-associated parameters in Bcl-2-or Neo-transfected T cell hybdridoma cells. 2B411 cells stably transfected with the human bcl-2 gene or a neo control vector were cultured during 12 h in the presence or absence of 50 mM t-BHP or 100 mM diamide, followed by determination of the following apoptosis-associated parameters: propidium iodine (PI)-detectable loss of nuclear DNA, oligonucleosomal DNA fragmentation detected by agarose gel electrophoreses (a), loss of the DC m determined by the potential-sensitive dye DiOC 6 (3), increase in the generation of hydroethidine-sensitive ROS (b), phosphatidylserine exposure on the plasma membrane detected by an Annexin V-FITC conjugate, and loss of ethidium bromide (EthBr) exclusion (c). Results are representative of three independent experiments
Results
Diamide but not tert-butylhydroperoxide overcomes the apoptosis-inhibitory eect of Bcl-2 Both the thiol-crosslinking agent diamide and the ROS donor t-BHP induce apoptosis (Hockenbery et al., 1993; Kane et al., 1993; Marchetti et al., 1997; Sato et al., 1995) . When comparatively assessing the pro-apoptotic eect of diamide and t-BHP on Bcl-2 overexpressing and control cells, we found that in control cells half-eective doses of these agents induce a similar pattern of chromatinolysis (assessed by agarose gel electrophoresis or staining with propidium iodide, Figures 1a and 2a) , phosphatidylserine exposure (assessed by FITCannexin V conjugates, Figure 1b) , cytolysis (assessed by ethidium bromide, Figure 1b) , and PARP cleavage (Figure 3d ). Transfection-enforced overexpression of human Bcl-2 protects against t-BHPinduced nuclear apoptosis and plasma membrane changes. However, it fails to provide signi®cant inhibition of diamide-induced apoptosis at the levels of DNA fragmentation, loss of plasma membrane asymmetry, and degradation of PARP (Figures 1a, 2a and 3c) . This dierential eect of Bcl-2 on t-BHP-and diamide-induced apoptosis was found in several cell lines, namely a T cell hybridoma cell line (Figure 1 ), CEM acute T cell leukemia cells ( Figure  2 ), and WEHI pre-B leukemia cells (not shown). Over a wide range of doses, diamide is approximately as ecient in inducing apoptosis in Bcl-2 hyperexpressing cells as it is in vector-transfected controls ( Figure 2 ). In conclusion, diamide reverses cytoprotection conferred by Bcl-2.
Dierential eects of diamide, ter-butylhydroperoxide and Bcl-2 on mitochondrial membrane function of intact cells
Since changes in mitochondrial membrane function are rate-limiting in many if not all models of apoptosis (Kluck et al., 1997; Kroemer et al., 1995; Liu et al., 1996; Susin et al., 1997a; Yang et al., 1997; , we investigated the eect of diamide and t-BHP on the DC m and on the mitochondrial generation of ROS. Both t-BHP and diamide induce a reduction in the incorporation of the potential sensitive dye DiOC 6 (3), followed by hypergeneration of hydroethidine-detectable ROS (Figures 1b, 2b and c). The diamide-and t-BHP-driven DC m disruption is not prevented by Z-VAD.fmk (Figure 3a) , a broadspectrum inhibitor of caspases and AIF. However, Z-VAD.fmk does block nuclear DNA fragmentation ( Figure 2b ) and PARP cleavage ( Figure 3d ) induced by diamide or t-BHP. Of note, Z-VAD.fmk only partially prevents cytolysis induced by t-BHP and diamide (Figure 3c ), thus con®rming the previously reported strong association between mitochondrial dysfunction and loss of cell viability (Boise and Thompson, 1997; Hirsch et al., 1997) . Bcl-2 protects against t-BHP-induced disruption of the DC m , yet fails to interfere with the diamide-triggered DC m collapse (Figures 1b and 2c) .
Altogether, these observations con®rm the strict correlation between the mitochondrion-stabilizing eect of Bcl-2 and its anti-apoptotic action. Moreover, they establish that the activation of Z-VAD.fmk-inhibitable proteases is secondary to the mitochondrial dysfunction induced by diamide and t-BHP. Eect of diamide and ter-butylhydroperoxide on isolated mitochondria overexpressing Bcl-2 Mitochondria puri®ed from control cells readily disrupt their DC m upon in vitro incubation with t-BHP or diamide. In contrast, mitochondria isolated from Bcl-2-transfected cells only lose their DC m in response to diamide, not with t-BHP (Figure 4a ). Since the DC m loss induced in isolated mitochondria is associated with the release of AIF and cytochrome c (Ellerby et al., 1997; Kantrow and Piantadosi, 1997; Susin et al., 1996; Zamzami et al., 1996) , we investigated the eect of diamide, t-BHP, and Bcl-2 on the liberation of these pro-apopotic proteins. As to be expected, the release of AIF (as determined in a cell-free system of nuclear apoptosis, Figure 4b ) and of cytochrome c (as determined by Western blot, Figure 4c ) correlates with the DC m loss. Both t-BHP and diamide favor the liberation of AIF and cytochrome c from control mitochondria. Only diamide aects Bcl-2 overexpressing mitochondria (Figure 4) . Thus, the observations obtained in intact cells (Figures 1 ± 3 ) extend to isolated mitochondria (Figure 4 ), in the sense that Bcl-2 stabilizes mitochondrial membranes and that this effect can be reversed by diamide but not by t-BHP.
Diamide but not ter-butyldroperoxide enforce opening of the mitochondrial megachannel reconstituted in liposomes containing recombinant Bcl-2 or Bcl-X L To gain insights into the site of action of t-BHP, diamide, and Bcl-2, we generated a reduced, cell-free, organelle-free system in which PTPC are reconstituted in liposomes (Beutner et al., 1996) . PTPC containing the ANT, cyclophilin D, porin, and hexokinase were enriched from rat brain and incorporated into liposomal membranes. In response to PTPC opening agents such as atractyloside or Ca 2+ , small molecules (51500 Da) such as malate (106 Da), ATP (509 Da), or calcein (622 Da) are readily released from such PTPC liposomes, suggesting a general increase in membrane permeability (Beutner et al., 1996; Marzo et al., 1998; O'Gorman et al., 1997) . We have taken advantage of this fact to equilibrate liposomes with the ampholytic¯uorochrome DiOC 6 (3) (573 Da), which freely distributes between the external and internal compartment, followed by cyto¯uorometric determination of DiOC 6 (3) retention. We interpret a reduction in DiOC 6 (3) retention (which correlates with an increase in malate, ATP, or calcein eux) (Beutner et al., 1996; Marzo et al., 1998; O'Gorman et al., 1997) to re¯ect an increase in membrane permeability. As shown in Figure 5a , t-BHP and diamide cause DiOC 6 (3) eux from control liposomes containing PTPC, yet fail to act on liposomes generated in the absence of PTPC (not shown). Pretreatment with monochlorobimane, which reacts with thiols to produce thiol esters, prevents the DiOC 6 (3) eux induced by either t-BHP or diamide ( Figure. 5A ), thus con®rming previous reports implying thiol groups in both t-BHP-and diamide-induced PT (Costantini et al., 1995 (Costantini et al., , 1996 Marchetti et al., 1997; Petronilli et al., 1994) . Recombinant Bcl-2 protein incorporated into PTPC liposomes protects against the t-BHP-but not against the diamide-induced loss of DiOC 6 (3)¯uorescence. Mutant Bcl-2 proteins which have lost their apoptosis inhibitory potential, namely the deletion mutant Bcl2Da5/6 (Schendel et al., 1997) and a Bcl-2 point mutant, Bcl-2(Gly145Ala) (Ying et al., 1994) , are inecient inhibitors of the t-BHP-triggered DiOC 6 (3) eux (Figure 5a ), although they are eciently incorporated into PTPC liposomes (Figure 5b ). Eect of t-BHP, diamide, and recombinant Bcl-2 proteins on PTPC reconstituted in liposomes. (a) PTPC lipsomes were generated in the presence or absence of recombinant Bcl-2, Bcl-X L , or mutated proteins, as detailed in Materials and methods, and treated with SDS (100 mg/ml), monochlorobiman (MCB; 50 mM), t-BHP (50 mM), and/or diamide (100 mM), stained with DiOC 6 (3), and subjected to¯ow cytometric analysis. Note that only Bcl-2 and Bcl-X L , not two Bcl-2 mutants (Gly145Ala and Da5/6) are capable of neutralizing the t-BHP eect on liposomes. Similar results have been obtained in ®ve (Bcl-2, Bcl-X L ) and three (Gly145Ala and Bcl-2Da5/6) experiments, respectively. (b) Control experiment to determine the incorporation of Bcl-2, Bcl-2 mutants, and Bcl-X L into liposomes. Liposomal preparations were generated in the presence of the indicated protein, washed, and subjected to protein extraction, Western blotting, and immunochemical detection of Bcl-2 and Bcl-X L , respectively. (c) Eect of t-BHP and diamide on cytochrome c encapsulated into PTPC liposomes. Cytochrome c was incorporated into PTPC liposomes which were treated with the detergent SDS, t-BHP, and diamide as in a. The liberation of cytochrome c into the supernatant (1610 5 g, 60 min) was measured by immunoblot as in Figure 4d Bcl-X L behaves like Bcl-2 and selectively antagonizes t-BHP in this reconstituted system. As a side observation, diamide and t-BHP do not cause the release of the 14 kDa protein cytochrome c encapsulated into PTPC liposomes (Figure 2c ), in line with the previously reported cut-o (1500 Da) of PTPC (Kinnally et al., 1996; Zoratti and SzaboÁ , 1995) . Altogether, the above data underline that t-BHP, diamide, and Bcl-2 directly act on PTPC to modulate apoptosis.
Discussion
Diamide: a strategy for overcoming Bcl-2 mediated apoptosis resistance?
Given the functional impact of Bcl-2 related proteins in cancer biology, it is important to conceive strategies to reverse Bcl-2 mediated apoptosis resistance. Apoptosis inducing protocols that overcome Bcl-2 include primary activation of caspases via death domain-containing receptors of the CD95/TNF-R receptor family (Huang et al., 1997; Susin et al., 1997a) or chemotherapeutic agents acting on microtubules such as taxol which may provoke Bcl-2 inactivation via hyperphosphorylation (Haldar et al., 1995 (Haldar et al., , 1996 . The resistance of diamide to Bcl-2 mediated cytoprotection suggests an additional strategy. Diamide is a glutathione-depleting agent and directly aects thiol residues in proteins. It is by virtue of this latter eect that it causes apoptosis (Sato et al., 1995) . The exact nature of the critical apoptosisregulatory proteins aected by diamide has not been elucidated. However, our previous work suggests that proteins from the mitochondrial inner membrane are critical targets for diamide . As shown here, diamide overcomes the cytoprotective and mitochondria-sparing eects of Bcl-2. This has been observed in cells (Figures 1 ± 3 ), isolated mitochondria (Figure 4) , and liposomes containing the reconstituted mitochondrial PTPC (Figure 5 ). The failure of Bcl-2 to confer resistance to diamide extends to both the inner transmembrane DC m and to the barrier function of the outer membrane. Thus, in conditions in which Bcl-2 prevents t-BHP-induced liberation of AIF and cytochrome c, it does not counteract diamide-triggered AIF and cytochrome c release via the outer membrane (Figure 4) . Concomitantly, Bcl-2 stabilizes the inner membrane proton gradient when mitochondria are treated with t-BHP, atractyloside Zamzami et al., 1996) or protoporphyrine IX (Marchetti et al., 1996b) , but not when they are treated with diamide ( Figure 4) .
Our data thus indicate that diamide induces apoptosis by enforcing mitochondrial membrane changes even in Bcl-2-overexpressing cells. This eect of diamide is likely to involve a direct action on PTPC ( Figure 5 ). Indeed, PTPC have been shown to possess a redox-sensitive site of critical vicinal thiols (Costantini et al., 1995; Petronilli et al., 1994) , which might be located within the ANT (Halestrup et al., 1997; Majima et al., 1993) . This putative site of diamide action is in redox equilibrium with glutathione (Costantini et al., 1995; Petronilli et al., 1994) , thus providing a hypothetical explanation for the fact that depletion/oxidation of glutathione facilitates disruption of the DC m (Reed and Savage, 1995; Zoratti and SzaboÁ , 1995) and induction of apoptosis (Beaver and Waring, 1995; Droge et al., 1994; Macho et al., 1997) , including in Bcl-2 expressing cells (Mirkovic et al., 1997) .
Altogether, it appears plausible that diamide causes apoptosis and reverses Bcl-2 cytoprotection by acting on PTPC.
Novel insights on the mode of action of Bcl-2
Most of the data obtained with Bcl-2 constructs targeted to dierent subcellular localizations suggest that Bcl-2 must act on mitochondria to prevent apoptosis (Kroemer, 1997; Reed, 1997; Wang et al., 1996; Zhu et al., 1996) . However, the submitochondrial mode of action of Bcl-2 has been controversial. By virtue of its C-terminal hydrophobic domain, Bcl-2 inserts into the outer mitochondrial membrane where it clusters in the contact sites with the inner membrane (Krajewski et al., 1993) . Bcl-2 prevents the loss of the inner DC m , which is due to opening of the PTPC formed in the contact site (Susin et al., 1997a; Zamzami et al., 1995 Zamzami et al., , 1996 . In addition, it inhibits the release of intermembrane proteins via the outer membrane (Kluck et al., 1997; Susin et al., 1997a; Yang et al., 1997; Zamzami et al., 1996) . It has been suggested that Bcl-2 would primarily aect the release and/or inactivation of cytochrome c and that this eect would then account for its capacity to prevent PT (Adachi et al., 1997; Kluck et al., 1997; Yang et al., 1997) . However, the data presented herein indicate that Bcl-2 can block PT induced in an arti®cal system in which PTPC are incorporated into liposomes ( Figure  5 ). This would suggest that Bcl-2 can aect mitochondrial functions such as PT independently from its eect on cytochrome c release.
The PTPC is a structure which participates in the regulation of matrix Ca 2+ , pH, DC m and volume and functions as a Ca 2+ -, voltage-, pH-and redox-gated channel with several levels of conductance. Its maximum conductance has been reported to be about 2 nS with a molecular cut-o of 1500 Da (Kinnally et al., 1996; Zoratti and SzaboÁ , 1995) . Accordingly, the PTPC does not allow for the extrusion of the 14 kDa protein cytochrome c (Figure 5c ). As a consequence, the putative relationship between PT and intermembrane protein release must be indirect. In isolated mitochondria, induction of PT can provoke cytochrome c eux, at least in vitro (Ellerby et al., 1997; Kantrow and Piantadosi, 1997) . However, the structure via which cytochrome c (and AIF?) extrudes, e.g. speci®c protein channels versus locally disrupted membranes, remains elusive.
Altogether, the ®ndings reported in this work indicate that the mechanism of the cytoprotective eect of Bcl-2 must be ascribed, at least in part, to an inhibitory eect on PTPC. In addition, our data suggest a strategy for reversing the anti-apopotic, oncogenic potential of Bcl-2.
Materials and methods
Cell lines and cell culture 2B4.11 T cell hybridoma cell lines stably transfected with a SFFV.neo vector containing the human bcl-2 gene or the neomycin resistance gene (Neo) only (Green et al., 1994) were kindly provided by Jonathan Ashwell, NIH). Human CEM-C7.H2 T lymphoblastic leukemia cells (StrasserWozak et al., 1995) were transfected with pEF-tTA, a doxycyclin-inhibitable transactivator (tTa) and supertransfected with a tTa-repressed bcl-2 construct in a tkHyg selection vector (pUGD10-3 Bcl-2 tkHyg; (Gossen and Bujard, 1992; Hartmann et al., in preparation) . For the repression of Bcl-2 expression, cells were cultured with 10 nM doxycycline for 48 ± 60 h prior to stimulations with apoptosis inducers. Results are shown for clone 9C3 overexpressing Bcl-2 as compared to a clone transfected with selection vectors only. All cell lines were cultured in RPMI 1640 supplemented with 10% FCS, antibiotics, and L-glutamine, and b-mercaptoethanol (for murine cells), in the presence or absence of ter-butylhydroperoxide (tBHP, Sigma, St Louis, MO) or diazenedicarboxylic acid bis 5N,N-dimethylamide (diamide, Sigma).
Cyto¯uorometric determination of apoptosis-associated parameters in whole cells
Following published protocols Marchetti et al., 1996a; Zamzami et al., 1995) , the following¯uorochromes were employed to determine dierent apoptosis-associated changes: 3,3'dihexyloxacarbocyanine iodide (DiOC (6) 3, 20 nM) for DC m quantification; hydroethidine (HE, 4 mM) for the determination of superoxide anion generation; or annexin V-FITC conjugates (1 mg/ml; Nexin Research, Hoeven, The Netherlands) for determination of phosphatidyl serine (PS) exposure on the outer plasma membrane. The frequency of subdiploid cells was determined by propidium iodide (PI) staining of ethanol-permeabilized cells. DNA fragmentation (5610 5 cells/lane) was determined by agarose gel electrophoresis .
Assessment of mitochondrial permeability transition
Mitochondria were puri®ed from cells disrupted by nitrogen cavitation. 3610 7 to 1610 8 cells were suspended in M buer (1 ml 300 mM sucrose+0.2 mM EGTA+5 mM Ntris[hydroxymethyl]methyl-2-Aminoethanesulfonic acid, pH=7.2), washed (600 g, 10 min, RT) twice in this buer, exposed to a nitrogen decompression of 150 Psi during 30 min using a`cell disruption bomb' (Parr Instument Company, Moline, IL, USA). The cell lysate was centrifuged twice (760 g, 10 min) to remove nuclei, and the supernatant was centrifuged again (8760 g, 10 min) to recover the mitochondrion-containing pellet. For the induction of PT, mitochondria from dierent 2B4.11 cells lines were incubated with atractyloside, t-BHP or diamide, followed assessment of mitochondrial large amplitude swelling and collapse of the DC m . For determination of swelling, mitochondria were washed and resuspended in CFS buer (220 mM mannitol; 68 mM sucrose, 2 mM NaCl, 2.5 mM PO 4 H 2 K, 0.5 mM EGTA, 2 mM MgCl 2 , 5 mM pyruvate, 0.1 mM phenylmethyl sulfonyl¯uoride [PMSF] , 1 mM dithiotreitol, 10 mM HEPESNaOH, pH 7.4; supplemented with 2 mM ATP) at a concentration of approxiametely 100 mg mitochondrial protein/100 ml buer. The DC m was measured using DiOC 6 (3) (40 nM; 15 min at 378C; Molecular Probes), after having added the indicated PT inducer (30 min, room temperature). Mitochondria were analysed in an Elite cyto¯uorometer (Coulter). Supernatants from mitochondria (150 000 g; 1 h; 48C) were frozen at 7808C until determination of AIF activity or immunodetection of cytochrome c.
Cell-free system of apoptosis
Nuclei from HeLa cells (puri®ed on a sucrose gradient, as described (Lazebnik et al., 1993) were cultured in the presence of mitochondrial supernatants for 90 min at 378C. Nuclei were stained with propidium iodide (PI; 10 mg/ml; Sigma), followed by cyto¯uorometric analysis in an EPICS Pro®le II Analyzer (Coulter, Hialeh, FL) (Susin et al., 1997b) .
Immunoblots
Western blots (reducing conditions) were revealed using monoclonal antibodys recognizing cytochrome c (clone 7H8.2C12, Pharmingen, Ref. (Liu et al., 1996) ) or poly(ADP-ribose) polymerase (PARP: mAb C2-10 purchased from Guy Poirier, Montreal University, Canada), or polyclonal antisera recognizing Bcl-2 (speci®c for residues 20-34; Calbiochem, La Jolla, CA) or Bcl-X L (Ab-1, Calbiochem), following standard procedures.
Recombinant Bcl-2 derivatives
Recombinant human Bcl-X L (1 ± 209), Bcl-2 (1 ± 218), mutant Bcl-2(Gly145Ala) and Bcl-2Da5/6 (Bcl-2 (D143 ± 184), all lacking the hydrophobic transmembrane domain (D219 ± 239 in the case of Bcl-2; D210 ± 230 for Bcl-X L ) and tagged N-terminally with His 6 , were produced and puri®ed as described (Schendel et al., 1997) .
Reconstitution of permeability transition pore complexes in liposomes
PTPC were puri®ed and reconstituted in liposomes following published protocols (Beutner et al., 1996) . Brie¯y, four Wistar rat brains were homogenized in buer 1 (1 mM amonothioglycerol, 10 mM glucose, pH 8.0, 40 ml), washed twice (15 min, 12 000 g, 48C) and resuspended in buer 1 plus 0.5% Triton X-100 (Boehringer Manheim) for 30 min at RT. Supernatants (40 min, 50 000 g, 48C) of this mixture were mixed with 17 g DE52 resin previously equilibrated with buer 2 (1.5 mM Na 2 HPO 4 , 1.5 mM K 2 HPO 4 , 100 mM glucose, 1 mM dithioerythitol, pH 8.0). These beads were packed into an FPLC column (XK16/20, Pharmacia Biotech) and eluted on a linear gradient KCl gradient (50 ± 400 mM). The three fractions containing maximum hexokinase activity (EC 2.7.1.1], eluting at 180 ± 200 mM KCl, were pooled for reconstitution into liposomes (5 : 1 phosphatidylcholine : cholesterol, resuspended in 3 ml 125 mM sucrose+10 mM HEPES (pH 7.4)+0.3% n-octyl-b-Dpyranoside) by overnight dialysis at 48C against 4.5 l 125 mM sucrose+10 mM HEPES. During the dialysis step, 30 mg/ml (corresponding to approximately 5% of the total PTPC proteins) recombinant Bcl-2, Bcl-X L , or mutated Bcl-2 proteins were added. Liposomes recovered from dialysis were ultrasonicated (120 W, Ultrasonic Processor, Bioblock) during 7 s in the presence of 10 mM KCl, charged on a Sephadex G50 columns (C16/20, Pharmacia), and eluted with 125 mM sucrose+10 mM HEPES. The fraction containing maximum hexokinase activity was recovered for functional analysis. 10 ml aliquots (approximately 10 7 ) of liposomes were incubated during 15 min at RT in 125 mM sucrose+10 mM HEPES supplemented with the indicated dose of monochlorobiman, diamide, and/or tBHP. Diluted (1 ml) liposomes (DC L ) were equilibrated with 3,3'dihexyloxacarbocyanine iodide (DiOC 6 (3), 80 nM, 20 min at RT; Molecular Probes). Thereafter, the retention of DiOC 6 (3) was measured in a FACS-Vantage cyto¯uorometer (Becton Dickinson), while gating the forward and side scatters on the quantitatively most abundant population of liposomes.
Abbreviations DCm, mitochondrial transmembrane potential; mClCCP, carbonylcyanide m-chlorophenylhydrazone; diamide, diazenedicarboxylic acid bis 5N,N-dimethylamide; DiOC 6 (3), 3,3'dihexyloxacarbocyanine iodide; Eth, ethidium; HE, hydroethidine; PARP, poly (ADP-ribose) polymerase; PI, propidium iodine; PT, permeability transition; PTPC, permeabilit transition pore complex; tBHP, ter-butylhydroperoxide, Z-VAD.fmk, N-benzyloxycarbonyl-Val-AlaAsp-¯uoromethylketone.
